THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner

SIMPLE SUMMARY: Glioblastoma (GBM) is the most frequent primary brain tumor entity with poor prognosis and resistance to current standard therapies. Cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD) are discussed as promising compounds for individualized treatment, as they exert...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolbe, Marc Richard, Hohmann, Tim, Hohmann, Urszula, Ghadban, Chalid, Mackie, Ken, Zöller, Christin, Prell, Julian, Illert, Jörg, Strauss, Christian, Dehghani, Faramarz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959141/
https://www.ncbi.nlm.nih.gov/pubmed/33802282
http://dx.doi.org/10.3390/cancers13051064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959141/
https://www.ncbi.nlm.nih.gov/pubmed/33802282
http://dx.doi.org/10.3390/cancers13051064

Ejemplares similares